Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SRT2104 endotoxin-induced inflammation study
NL-OMON21773Not yet recruiting
- Sponsor
- Academic Medical Center
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Double-blind trial of SRT2104 in chronic inflammation, sepsis and Gram-negative bacterial infection (3 arms), sponsored by Academic Medical Center. Primary endpoints: Clinical signs and symptoms of endotoxin-induced inflammation, Inflammatory cytokines and 3 more. Planned start Nov 2009; status: not yet recruiting.
02
Drugs
SRT2104
03
Conditions
chronic inflammationsepsisGram-negative bacterial infection
Beyond the preview
Go deeper on NL-OMON21773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21773.